The efficacy and safety of pemetrexed-based doublet therapy compared to pemetrexed alone for the second-line treatment of advanced non-small-cell lung cancer: an updated meta-analysis

BACKGROUND: Pemetrexed is currently recommended as the second-line treatment for patients with advanced non-small-cell lung cancer (NSCLC). However, it is unclear whether pemetrexed-based doublet therapy improves treatment efficacy and safety. Thus, this meta-analysis was performed to resolve this c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Drug Des Devel Ther
Main Authors: Zhong, Anyuan, Xiong, Xiaolu, Shi, Minhua, Xu, Huajun
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2015
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4516195/
https://ncbi.nlm.nih.gov/pubmed/26229433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S88218
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki